UNICOR-v has the potential to protect against future epidemics caused by a coronavirus jumping from animals to humans, but also against new variants emerging from SARS-Cov-2
100% efficacy against severe Covid-19 disease and hospitalizations
Heterologous booster vaccination refers to the use of vaccine boosters from different technology platforms from the prime vaccines, which could improve the overall immune response and enhance protection against other variants
CEPI is accelerating its programme to develop broadly protective coronavirus vaccines—a core part of US $ 3.5 billion pandemic preparedness plan
Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Canada
AptarGroup acquired Voluntis and 80% of Weihai Hengyu Medical Products in 2021.
New subsidiaries to be established in Malaysia, Taiwan, Singapore, and Hong Kong
The KRIVIDA Novus RT-PCR kit can detect the Omicron variant, its sub-lineages, and the Delta variant in 45 minutes
Bebtelovimab neutralizes Omicron as demonstrated by pseudo virus and authentic virus data
Immune responses were about two-to-three-fold higher in adolescents than in adults against all variants studied. Vaccine was well-tolerated with no safety signals identified
Subscribe To Our Newsletter & Stay Updated
